Obesity Clinical Trial
Official title:
Healthy Eating for Reproductive Health (HERHealth)
This study will be a 6-month intervention that is examining how different dietary approached may be useful for women with Polycystic Ovarian Syndrome (PCOS) who are attempting pregnancy, particularly by measuring changes in weight. Participants will be randomly assigned to following one of two dietary approaches for weight loss: 1) a low-calorie approach to weight loss (reducing caloric intake by approximately 500 calories per day) or 2) a low-fat, low-glycemic index vegan diet. A vegan diet is one that does not contain any animal products (no meat, fish, poultry, eggs, or dairy) but emphasizes plant-based foods, such as fruits, vegetables, whole grains, and legumes/beans. In addition, this diet will be low-glycemic index, which means you will be asked to favor foods that don't cause a quick rise in blood sugar (for example, favoring oatmeal over cornflakes for breakfast). Participants will receive counseling and supporting materials on the dietary approach you are assigned to follow. Both diets are safe and have shown to be effective ways to assist with achieving a healthy weight. The investigators hypothesize that both groups will see improvements in weight and fertility with possible greater improvements seen among participants in the vegan group.
This study involves two groups. You will be randomly assigned to one of these groups (i.e.
you do not have a choice for group assignment) which means your group will be assigned to you
by chance, like flipping a coin. Both groups will be assigned to receive information on a
dietary approach to lose weight. One group will receive instruction on a low-calorie approach
to weight loss (reducing caloric intake by approximately 500 calories per day). The other
group will be instructed on how to follow a low-fat, low-glycemic index vegan diet. A vegan
diet is one that does not contain any animal products (no meat, fish, poultry, eggs, or
dairy) but emphasizes plant-based foods, such as fruits, vegetables, whole grains, and
legumes/beans. In addition, this diet will be low-glycemic index, which means you will be
asked to favor foods that don't cause a quick rise in blood sugar (for example, favoring
oatmeal over cornflakes for breakfast). Below are the steps in the study:
- If you are accepted into the study, you will come to the study site (USC School of
Public Health) to learn more about the study and complete your consent form. If you live
outside the Columbia, SC area (more than a 6o mile drive), then you may complete
orientation to the study over the phone and Web. You will then be mailed a consent form
which we will discuss over the phone. You can then sign the consent form (keeping one
copy for yourself and having a witness sign it as well) and mail it back. Once that is
received by study personnel, a copy with a research personnel's signature will be mailed
back to you. You may then begin the study.
- This study will involve 3-4 in-person visits to the School of Public Health at USC's
Columbia campus, each lasting less than 2 hours each.
- You will then complete some questionnaires that will measure your diet and physical
activity levels at home from a computer.
- You will come back for a meeting to have your weight, height, waist, and hip
circumference measured. You will then be randomly assigned to one of the two groups:
calorie controlled group or vegan diet group. You will receive a one-hour overview of
the diet you have been assigned to and be provided with materials on this diet.
- During the study, we will ask you to complete a weekly questionnaire which will assess
if you are following the diet, your weight, and ask for information on your menstrual
cycle. This will take approximately 5 minutes to complete.
- You will then be provided individualized feedback each week via e-mail on your progress,
along with a weekly lesson on the topic for the week.
- You will also have access to a group website (a private Facebook group) that will
provide group support. Participation using this group is optional.
- You will be provided with test strips to monitor ovulation each month and pregnancy
tests (1 per month) to monitor pregnancy status. You will report these results to us via
online survey.
- Study personnel will host a weekly 30 minute webinar for your diet group online. This
will take place after work time on a weekday. Make-up sessions by phone during the work
day will be available.
- At 3 months, you will be asked to complete another set of questionnaires from home and
return to our study site for your weight, waist, and hip circumference measurements. You
will receive a $10 incentive for completing the 3-month assessment. You will also
receive a $5 incentive each month that you provide your menstrual cycle data (using the
test strips) and pregnancy tests results—which you will receive at the 3 month meeting
(for a total of $25 possible at month 3).
- You will then continue the study for the next 3 months.
- At study completion (6 months), you will complete the last set of questionnaire (online
from home). Also, you will come to a follow-up assessment to be weighed, have your waist
and hip circumference measured, and to receive your incentive for participating ($10
+$5/month of each menstrual cycle data submitted for a total of $25 possible).
- If you become pregnant during the course of the study, you will be advised to consult
your care provider. Because this is a weight loss study, we cannot allow continued
participation but would like to record your weight measurement and other questionnaire
data prior to study discontinuation. If you choose to continue to follow your assigned
dietary approach, we can provide information on the diet to your physician, who can
advise you on how to proceed.
- Participants in both groups will be asked to take a daily prenatal vitamin (or other
reliable source of vitamin B-12) over the course of the study.
- During the study, we will ask you to keep your physical activity levels constant (keep
your levels the same as what you were doing at study entry).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |